NTRB - NutriBand Inc.

5.84
0.520   8.904%

Share volume: 53,832
Last Updated: 04-28-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 1.01%

PREVIOUS CLOSE
CHG
CHG%
$5.32
0.52
0.10%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
51%
Profitability 35%
Dept financing 24%
Liquidity 70%
Performance 70%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
9.77%
1 Month
-4.73%
3 Months
-20.11%
6 Months
-8.03%
1 Year
70.76%
2 Year
74.33%
Key data
Stock price
$5.84
P/E Ratio 
0.00
DAY RANGE
$5.33 - $6.66
EPS 
-$0.55
52 WEEK RANGE
$3.30 - $11.78
52 WEEK CHANGE
$68.79
MARKET CAP 
68.685 M
YIELD 
N/A
SHARES OUTSTANDING 
11.036 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-30-2025
BETA 
1.70
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$16,092
AVERAGE 30 VOLUME 
$15,056
Company detail
CEO: Gareth R. Sheridan
Region: US
Website: nutriband.com
Employees: 10
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl system.

Recent news
loading